Central Drug Agency Seeks Clarification From Glenmark On Its COVID Drug - Latest News

Breaking

Home Top Ad

Responsive Ads Here

Post Top Ad

Responsive Ads Here

Sunday, July 19, 2020

Central Drug Agency Seeks Clarification From Glenmark On Its COVID Drug

The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on...

from NDTV News - Latest https://ift.tt/eA8V8J https://ift.tt/3jjsiDu

No comments:

Post a Comment

Post Bottom Ad

Responsive Ads Here

Pages